GRAL vs MRK
GRAIL Inc. vs Merck & Co. — AI-powered side-by-side comparison
| Metric | GRAL | MRK |
|---|
| AI Score |
64
|
70
|
| Price |
$75.48
|
$130.34
|
| P/E Ratio |
-7.74×
|
103.53×
|
| ROE |
-15.8%
|
34.7%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
-10.8%
|
75.4%
|
| Debt / Equity |
0.04×
|
1.29×
|
| Dividend Yield |
0.0%
|
2.6%
|
| RSI (14) |
60.4
|
64.5
|
| Beta |
3.246
|
0.207
|
| Expected Upside |
—
|
—
|
AI Committee View
Current Innellis committee reasoning for GRAL versus MRK.
MRK leads by 6 points.
MRK scores 70/100 (Buy) versus GRAL at 64/100 (Buy).
GRAL Committee View
67% agreement
6 analysts
The primary driver is vix regime is low -- calm backdrop supports risk-taking. The main limiting factor is bollinger bandwidth of 20.8% signals elevated volatility. The committee is constructive but not yet at full conviction.
Bull Case
- Price-to-book of 1.3x is a discount to asset value — Value
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- ROE of only -16.4% -- cheap may mean cheap for a reason — Value
- Bollinger bandwidth of 20.8% signals elevated volatility — Risk
MRK Committee View
75% agreement
4 analysts
The primary driver is 5 consecutive earnings beats -- consistent execution. Most analysts agree, and no major concerns are blocking a stronger rating.
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
Bear Case
- MACD histogram negative -- bearish momentum — Technical